Regencell Bioscience Holdings Limited (RGC)
Healthcare · Drug Manufacturers - Specialty & Generic
1 member of Congress has disclosed 2 trades in Regencell Bioscience Holdings Limited (RGC) since 2017: 0 buys and 2 sales. The most recent was disclosed on Dec 21, 2017.
- Trades disclosed
- 2
- Members trading
- 1
- Buys / sells
- 0 / 2
- Reported value
- $1M–$2M
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at RGC
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded RGC
- Sen. Michael F. Bennet (D-CO)0 buys · 2 sales02Dec 21, 2017
All trades
- Dec 21, 2017$500K–$1M
Sen. Michael F. Bennet (D-CO)
Sold (full) Regencell Bioscience Holdings Limited RGC
$500K–$1M · Traded Dec 8, 2017 · disclosed Dec 21, 2017
- Apr 10, 2017$500K–$1M
Sen. Michael F. Bennet (D-CO)
Sold (partial) Regencell Bioscience Holdings Limited RGC
$500K–$1M · Traded Mar 28, 2017 · disclosed Apr 10, 2017
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.